Clinical Trial Update: Addition of Spironolactone in Patients With Resistant Arterial Hypertension [Phase 4]

View source ↗

Summary

This clinical trial update notes the addition of spironolactone to the treatment regimen for patients with resistant arterial hypertension in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Jan Vaclavík | Conditions: Hypertension | Phase 4 | Status: UNKNOWN